Visterra
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
Key facts
| Also Known As | Parasol Therapeutics |
|---|---|
| AngelList URL | https://angel.co/visterra |
| CAGE Code | 6G8T0 |
| Legal Name | Visterra, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/visterra |
| Full Address | 275 2nd Avenue Waltham, MA 02451, United States |
| LinkedIn URL | https://www.linkedin.com/company/visterra-inc-/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/44158-15#overview |
| Previous Name | PARASOL THERAPEUTICS INC |
| Twitter URL | https://twitter.com/visterra_inc |
| Official Website | http://www.visterrainc.com |
| Wellfound ID | visterra |
| Wikidata ID | Q30269387 |
| YouTube Channel | https://www.youtube.com/channel/UCKMBXGuU6HUqGv7R0AwHarg |
Contact details
Email and phone for Visterra are available to signed-in members of PharmaLyt.
Sign in to view